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MigrationCardiac neural crest cells migrate into the pharyngeal arches where they support development of the
pharyngeal arch arteries. The pharyngeal endoderm and ectoderm both express high levels of FGF8. We
hypothesized that FGF8 is chemotactic for cardiac crest cells. To begin testing this hypothesis, cardiac crest
was explanted for migration assays under various conditions. Cardiac neural crest cells migrated more in
response to FGF8. Single cell tracing indicated that this was not due to proliferation and subsequent transwell
assays showed that the cells migrate toward an FGF8 source. The migratory response was mediated by FGF
receptors (FGFR) 1 and 3 and MAPK/ERK intracellular signaling. To test whether FGF8 is chemokinetic and/or
chemotactic in vivo, dominant negative FGFR1 was electroporated into the premigratory cardiac neural crest.
Cells expressing the dominant negative receptor migrated slower than normal cardiac neural crest cells and
were prone to remain in the vicinity of the neural tube and die. Treating with the FGFR1 inhibitor, SU5402 or
an FGFR3 function-blocking antibody also slowed neural crest migration. FGF8 over-signaling enhanced
neural crest migration. Neural crest cells migrated to an FGF8-soaked bead placed dorsal to the pharynx.
Finally, an FGF8 producing plasmid was electroporated into an ectopic site in the ventral pharyngeal
endoderm. The FGF8 producing cells attracted a thick layer of mesenchymal cells. DiI labeling of the neural
crest as well as quail-to-chick neural crest chimeras showed that neural crest cells migrated to and around the
ectopic site of FGF8 expression. These results showing that FGF8 is chemotactic and chemokinetic for cardiac
neural crest adds another dimension to understanding the relationship of FGF8 and cardiac neural crest in
cardiovascular defects.s (Neonatology), Box 103105,
SA. Fax: +1 919 668 1599.
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FGF8 is produced by the lateral pharyngeal endoderm and
ectoderm during development of the pharyngeal arches and is critical
for their formation. However, the varied roles of FGF8 in pharyngeal
development have been difﬁcult to elucidate because targeted
disruption of the fgf8 gene in mice causes the embryos to die at
mid-gastrulation (Sun et al., 1999) making it impossible to assess
their role in later development. Some information has been available
from fgf8 hypomorphic mice that produce enough FGF8 for the
embryos to survive through organogenesis and show that FGF8
signaling is critical for normal development of the pharynx and heart
as well as neural crest cells migrating to these structures (Abu-Issa
et al., 2002; Frank et al., 2002). The neural crest cells required for
cardiac development originate from postotic rhombomeres 6, 7 and
8 and migrate to the caudal pharynx (arches 3–6). They are important
for normal conversion of the aortic arch arteries to the great arteries(Le Lievre and Le Douarin, 1975; Waldo et al., 1996). A subset of these
cells migrates to the arterial pole where they form the aorticopul-
monary septation complex which divides the arterial pole into
systemic and pulmonary channels (Kirby et al., 1983). Formation of
the pharyngeal pouches/grooves which is dependent on FGF8
signaling, is important to restrict the cranial neural crest streams to
particular pharyngeal arches (Trumpp et al., 1999).
FGF8 signaling also has important functions during early stages of
neural crest development. During early neural crest speciﬁcation, FGF
signaling is needed for expression of slug, a transcription factor
required for neural crest delamination and migration. In Xenopus,
overexpression of a dominant negative FGF receptor 1 leads to a loss
of neural crest formation in Xenopus embryos (Mayor et al., 1997).
However, these embryos experience loss of FGFR1 signaling from the
single cell stage, making it likely that the neural plate/tube is not
normally patterned. Wnt and FGF8 signals act in parallel at the neural
border converging on Pax3 activity, which in turn activates slug
(Monsoro-Burq et al., 2005).
In an environment of reduced FGF8 signaling, as in fgf8
hypomorphic mice, neural crest cells are speciﬁed and seem to
begin migration in normal numbers but not enough FGF8 is available
to support viability of the cells. Some of the cells die as they leave the
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death (Abu-Issa et al., 2002; Frank et al., 2002) leading to various
defects in pharyngeal arch artery patterning and in the cardiac
outﬂow tract that represent a combination of outﬂow malalignment
and outﬂow septation defects.
Our understanding of the role of pharyngeal FGF8 has been further
reﬁned by conditional deletion of FGF8 in the pharyngeal ectoderm
and endoderm. Conditional deletion in the pharyngeal ectoderm led
to the failure of arch artery 4 to develop while conditional deletion in
the endoderm led to a failure in outﬂow tract septation (Park et al.,
2006). Failure in arch artery 4 development was not attributable to
neural crest while outﬂow tract septation was attributed to the
reduced number of cardiac neural crest cells. Thus there are several
points during neural crest speciﬁcation and migration into the
pharynx that require FGF8 signaling.
It has recently been demonstrated that neural crest cells migrating
to pharyngeal arch 2 are attracted there by VEGF signaling (McLennan
et al., 2010); however, VEGF is not chemoattractant for cardiac neural
crest cells and it is not known if cardiac crest cells are chemoattracted
to the caudal pharynx. Some evidence suggests that neural crest cells
are attracted to FGF8. After ablation of the preotic neural crest which
results in a dramatic decrease in FGF8 expression in the frontonasal
process and pharyngeal ectoderm, postotic crest can be induced to
migrate into the frontonasal process and pharyngeal arch 1 by placing
a bead of FGF8 near pharyngeal arch 1 (Creuzet et al., 2002). While it
was speculated that the postotic crest was attracted to the region by
FGF8, this hypothesis was never rigorously tested.
Two studies have shown FGF8 to be a chemoattractant or
chemorepellent for migrating cells depending on context and cell
population. Newly gastrulated mesoderm cells migrating from the
primitive streak are repelled by FGF8 and attracted to the notochord
by FGF4 (Yang et al., 2002). By contrast mesencephalic neural crest
cells are attracted to a source of FGF8 in vitro (Kubota and Ito, 2000).
In vivo, FGF8 was found to be important for the localization of FGF2,
which acted as the chemotactic agent. The chemotaxis was mediated
by high afﬁnity FGF receptors (FGFR) 1 and 3.
This paper reports a series of experiments designed to evaluate the
role of FGF8 signaling in cardiac neural crest cell migration to the
caudal pharyngeal arches. Explanted premigratory cardiac neural
crest cells showed a dose-dependent increase in migration index and
enhanced single cell migration in the presence of FGF8. Transwell
assay showed the explanted cardiac neural crest cells migrate toward
an FGF8 source. The migration effect was mediated by FGFR1 and R3
and the Mek/Erk, PI3K and p38 intracellular pathways. In vivo,
treatment of embryos with SU5402 to block FGF signaling or
expression of dominant negative FGFR1 delayed cardiac neural crest
migration and enhanced cardiac neural crest cell death. Finally, the
cardiac neural crest cells are attracted to ectopic sites of FGF8
overexpression. These results indicate that FGF8 is chemotactic and
chemokinetic for cardiac neural crest cells and gives another basis for




The premigratory neural folds were dissected cleanly from the
neural tube between the mid-otic placode and somite 3 as previously
described (Kirby et al., 1997). The neural folds were plated on
ﬁbronectin (BD Sciences)-coated 8-well glass slides and cultured on a
heated stage (LiveCell, Westminster, MD) overnight in 5% FBS in
Liebovitz's L-15 (Gibco) medium with high glucose in the absence of
CO2. Timelapse images were captured every 10 min for a 16 h period
using a Nikon Eclipse TE2000-U microscope and MetaMorph image
analysis software. Cell migration indices were quantiﬁed as reportedpreviously (Huang et al., 1998). Differences in migration area
resulting from random variation in the size/shape of the explant
were controlled by dividing the outgrowth area (mm2) by the
perimeter (mm) of the explant. This normalized number is referred to
as the migration index and provides an estimate of the migration rate
of the neural crest cells. A minimum of nine explants per treatment
was recorded.
For single cell analysis total distances that each cell moved were
traced and calculated and normalized for the amount of time that the
cell was visible in the plane of the recorded images as previously
reported by the Lo lab (Xu et al., 2006). At least ﬁve cells per
experimental condition were quantiﬁed. Because directionality of
neural crest movement in culture is more dependent on repulsive
forces of the neural fold, directionality was not noted so only the total
distance the cell moved is reported. Statistical signiﬁcance was
determined using a one-way ANOVA; post-hoc analysis, if necessary
(ANOVA pb0.05), was done using an unpaired Student's t-test with
equal variances.
Chemotaxis assays were performed using ChomoTx Chemotaxis
System (NeuroProbe, Inc.). The assays were performed in a 96 well
format with an 8 μm pore size. For each experiment 24 neural folds
were removed from mid-otic placode to somite 3 from HH9 embryos,
rinsed in 2% FBS/L-15 medium, and further dissected into small pieces
to facilitate cell dissociation. The pieces were dissociated for 5 min at
37 °C in 0.25% Trypsin–EDTA (Sigma). Media containing 5% FBS was
added and the cells were pelleted by a 5 min centrifugation at
1000 rpm. The dissociated cells were then resuspended in 750 μl of 5%
FBS/DMEM. The lower well was prepared with the following
treatments in replicates of 6: 2% FBS/DMEM medium (Control), 2%
FBS DMEM with 10 ng/ml FGF8 (human recombinant, PeproTech,
Inc.); 2% FBS DMEM with 30 ng/ml FGF8; 2% FBS DMEM with 10 mM
SU5402 (Tocris Biosciences). The dissociated cells were pipetted onto
the chemotaxis membrane and the plate incubated overnight at 37 °C,
5% CO2. The membrane was ﬁxed in ice-cold methanol (10 min 4 °C),
stained with Toluidine blue (0.1% in distilled water) for 3 min at room
temperature, rinsed gently in distilled H2O. The cells on the topside of
the Chemotaxis membrane were removed with a cotton swab. All of
the cells on the underside of the membrane were counted. The
experiment was repeated 6 times.
Inhibitors
All inhibitors were used at a concentration of 10 μM. The FGFR
blocking compound, SU5402 (Calbiochem or Tocris), and the Mek
inhibitor, U0126 (Promega), were both resuspended in DMSO. The
PLCγ inhibitor, U73122 (ENZO Life Sciences), was resuspended in
ethanol. For the in ovo SU5402 treatment, embryos were treated with
20 μl of 10 μM SU5402 in 1× PBS pH 7.4 as previously described
(Hutson et al., 2006). FGFR1 and R3 neutralizing antibodies were
made by New England Peptide (Gardner, MA) in rabbit using peptides
designed to the ligand binding domain. In the in vitro experiments the
function blocking antibodies were used at 5 μM concentrations. For in
vivo studies, embryos were treated with 20 μl of a 5 μM FGFR3
antibody in PBS alone or 20 μl of a solution containing 10 μM SU5402
and 5 μM FGFR3 antibodies.
Semi-quantitative PCR and quantitative PCR
RNA was extracted as described previously (Hutson et al., 2006).
cDNA was generated using SuperScript® II Reverse Transcriptase
according to the manufacturer's protocol. Primer sequences are
shown in Suppl. Table 1. BLAST analysis showed that the sequences
only aligned with the targeted genes. Only a partial sequence is
available for chick FGFR4; therefore, the exon–exon boundaries for
that gene remain unknown.
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pharynx or secondary heart ﬁeld was performed as previously
described (Hutson et al., 2006). The expression levels were normal-
ized to HPRT.
In situ hybridization
Whole mount in situ hybridization was carried out using a standard
protocol (Wilkinson, 1992). Previously published probes were used for
in situ hybridizations (Dessimoz et al., 2006; Harduf et al., 2005). To
conﬁrm that the primers were speciﬁc for the FGF receptors, the PCR
products were sequenced by the Duke Cancer Biology Sequencing
Facility.
Immunohistochemistry, cell proliferation and TUNEL assay
Immunohistochemistry was performed on parafﬁn or frozen
sections as detailed previously (Waldo et al., 1996). Antibodies used
were anti-phospho-Histone H3 (pHH3; Upstate), anti-GFP (Molecular
probes, Invitrogen), HNK1 (ATCC), anti-phospho-Erk (Cell Signaling
Technology) and anti-FGFR1 and R3 (see above). Apoptosis was
detected using ApopTag Red In Situ Apoptosis Detection Kit
(Chemicon) based on the TUNEL assay method. In all cases where
immunohistochemistry was performed controls were prepared
without addition of primary antibody.
FGF8 and dominant-negative FGFR1 (dnFGFR1) plasmids
Two plasmid vectors were used in the experiments to inhibit
FGFR1: a green-ﬂuorescent protein (GFP) control plasmid (pCCALL2
EGFP) and a dnFGFR1 plasmid with a GFP reporter (pCCALL2
dominant negative FGFRI IRES EGFP). Both plasmids were a gift
from Dr. Eric Meyers (currently at St. Luke's Boise Medical Center).
Two plasmids were used in experiments to overexpress FGF8b.
EGFP or FGF8b were cloned into the pMiwSV plasmid vector, which
has a chick β-actin promoter and RSV enhancer (Sato et al., 2001;
Suemori et al., 1990; Wakamatsu et al., 1997). Both plasmids were
gifts from Dr. H. Nakamura (Department of Molecular Neurobiology,
Institute ofDevelopment, AgingandCancer, Seiryo-machi 4–1, Aoba-ku,
Sendai 980-8575, Japan).
Electroporation
For the foregut electroporation studies eggs were incubated to
HH10–11. The eggs were windowed and the vitelline membrane was
torn. One or two drops of Ringers solution was applied so that the
embryo fell away from the vitelline membrane. Platinum electrodes
were placed at the cranial end on either side of the embryo. GFP or
FGF8-GFP expressing plasmid at 0.5–3.0 μg/μl was injected into the
foregut using a picospritzer. Three 50 ms square wave pulses were
immediately applied at 20 V each. If the embryo was electroporated
bilaterally, a drop of Ringers was again applied to the embryo, and
injection and electroporation were repeated for the other side of the
foregut. To label neural crest in some embryos, DiI (Invitrogen) was
injected into the neural tubes after electroporation.
For the morpholino studies carboxyﬂuorescein-tagged start site
morpholinos were designed by Gene Tools for FGFR1–3 and a control
scrambled morpholino (Suppl. Table 2). The morpholinos (2 mM)
were injected into the neural tube of HH9–11 chick embryos, and
electroporated bilaterally as described above. The electroporated
neural foldswere removed from the embryo and cultured overnight at
37 °C in the presence or absence of 30 ng/ml FGF8b in 5% FBS in L-15
with high glucose. Migration analysis of single ﬂuorescently-labeled
cells was performed as described above.For the dnFGFR1 studies, the dnFGFR1 was electroporated into the
neural tube as described above. Embryos were harvested at 24–48 h
after electroporations.
FGF8 bead experiments
Heparin beads (Sigma) were soaked overnight in 30 ng/ml of
FGF8b or PBS. FGF8 or PBS beads were implanted caudal to the otic
placode in HH10 embryos. Embryos were collected at HH14–15 and
immunostained for HNK1 in whole mount.
Statistical analysis
Migration data was analyzed by ANOVA followed by posthoc t-
tests. Signiﬁcance was set as p≤0.05. For qPCR the data was tested by
Kruskal–Wallis one-way analysis of variance by ranks. Signiﬁcance
was set as p≤0.05.
Results
FGF8 enhances cardiac neural crest migration
To test how FGF8b inﬂuences cardiac neural crest cell migration,
explanted premigratory cardiac neural crest cells were exposed
overnight to FGF8b protein. Cardiac neural crest cells migrated more
in the presence of increasing concentrations of FGF8b (2.5–30 ng/ml)
(Figs. 1A and B). The explants treated with 30 ng/ml FGF8b migrated
signiﬁcantly farther than control explants, and treatment with 10 μM
of the FGFR1 blocking drug SU5402, attenuated this response (Figs. 1A
and B) suggesting that FGF8b is chemokinetic for cardiac neural crest
cells.
VEGF has been shown to be chemotactic for the preotic cranial
crest migrating into pharyngeal arch 2 (McLennan et al., 2010). Since
VEGF is also expressed in the caudal pharynx it was tested for its
ability to enhance migration of the postotic-derived cardiac neural
crest. Cardiac neural crest explants were treated with several
concentrations of VEGF. The VEGF-treated cells showed no difference
in migration distances compared to controls (Fig. 1C). Because FGF3 is
expressed in rhombomere 6, one of the rhombomeres of origin of the
cardiac neural crest, it was also tested for the ability to promote
migration. FGF3 at 10 or 30 ng/ml did not affect cardiac neural crest
migration when compared to control (data not shown).
To rule out an effect of FGF8 on cardiac neural crest proliferation
that would appear as enhanced migration, individual cells were
tracked in time-lapse movies over a 16-hour period. Individual cells
treated with 30 ng/ml FGF8b migrated signiﬁcantly farther than
control cells (Fig. 1D) and inhibiting FGF signaling with SU5402
blocked this effect. Although less than 1% of the cell behaviors were
analyzed in each time-lapse movie all the cells in the FGF treatment
group migrated greater distances when compared to control or the
SU5402-treated group.
Taken together these results suggest that FGF8 is speciﬁcally
chemokinetic for the cardiac neural crest cells because it increases the
migratory behavior of the cells as a group and individually.
FGF8 is chemotactic for cardiac neural crest in vitro
The results above show that FGF8 may be a chemokinetic factor
but the experiments did not test for its capacity to inﬂuence the
directionality of the migrating cardiac neural cells or chemotaxis. To
determinewhether FGF8 is chemotactic for cardiac neural crest cells, a
standard chemotaxis transwell assay was performed using a ﬁlter
with 8 μm pores between the chambers. Dissociated cardiac neural
crest cells were equally distributed in the upper chamber with FGF8b
containingmedium in the bottomwell. A signiﬁcantly greater number
of cells migrated across the ﬁlter into the bottom chambers containing
Fig. 1. Cardiac neural crest cells migrate farther in response to FGF8. (A) Representative images of premigratory and postmigratory cardiac neural crest explants (10×). Explant
circumference is highlighted by a dotted line. Explants were grown overnight with FGF8b, SU5402, or both. (B) Dose–response of cardiac neural crest migration in the presence of
FGF8 is linear and can be blocked by the FGFR receptor blocker, SU5402. Asterisks indicate statistical signiﬁcance when compared to control. (C) Distance migrated by cardiac neural
crest cells is not altered by VEGF an established chemotaxic cytokine for neural crest migrating into pharyngeal arch 2. (D) Average length of themigration path of 5 individual neural
crest cells from real time imaging shows that individual cell movement is enhanced in the presence of FGF8b and reduced in the presence of SU5402. (E) Transwell assay showing
enhancedmovement of cardiac neural crest cells toward 10 or 30 ng/ml FGF8. Designation under each bar indicates contents of top and bottomwells. Control in the topwell included
DMEMwith 5% serum. The bottomwells all contained DMEMwith 2% serum (Control). Experimental bottomwells included either FGF8 or SU5402. There is no difference in Control/
Control versus Control/SU5402 indicating little to no FGF stimulation from the serum in the bottom well. Each bar represents the average of the total number of cells that migrated
across the membrane in 6 separate experiments. Within each experiment there were 6 replicates of each treatment condition.
21A. Sato et al. / Developmental Biology 354 (2011) 18–3010 or 30 ng/ml FGF8b when compared to wells with medium alone or
with FGF3 in the bottom well. When SU5402 was added to the
chambers, transwell migration was dramatically inhibited in the
presence of FGF8 (Fig. 1E). These results show that FGF8 is
chemotactic for the cardiac neural crest in vitro.FGFR1 and R3 mediate FGF8-induced cardiac neural crest cell migration
Asmentioned above there are several different FGF ligands that are
present in the pharynx, thus speciﬁcity of FGF signaling must be
achieved through different combinations of ligands and FGF receptors.
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sion of FGFR1–3 in mesencephalic chick neural crest cells both in
section and in culture. To determine which FGFRs are expressed in
premigratory cardiac neural crest and explants cultured for 24 and
48 h RT-PCR was performed. All four FGFRs are expressed in the
premigratory cardiac neural crest and expression was maintained in
culture at all of the times examined (Suppl. Fig. 1).
To determine which FGFRs are required for FGF8 signaling in
cardiac neural crest cell migration, we electroporated 3′-carboxy-
ﬂuorescein-tagged start site morpholinos designed against FGFR1–3
into neural tubes at HH9 and explanted the premigratory cardiac
neural crest for in vitro migration analysis. The distances that
individual ﬂuorescent cells moved over a 16-hour time period were
recorded by time-lapse videomicroscopy. Cells electroporated with
FGFR3 morpholino at HH9 migrated signiﬁcantly less than control
(Fig. 2A). FGFR1-morpholino electroporated cells tended to migrate
less than control but there was no change in migration with FGFR2
knockdown (Fig. 2A).
To achieve a greater knockdown effect of FGFR1 and R3 protein
expression, blocking antibodies to FGFR1 and FGFR3 were made.
Immunoﬂuorescence showed that both antibodies recognized popu-
lations of migrating cardiac neural crest in vivo with FGFR3 showing
more distinct colocalization with HNK1-positive neural crest cells
than FGFR1 (Fig. 2B). FGFR1 was broadly expressed in the pharyngeal
mesenchyme and neural tube but was more strongly associated with
the “migratory front” of the cardiac neural crest while FGFR3 was
more localized to the cardiac neural crest. To determine the ability of
these antibodies to block FGF8-induced migration, premigratory
cardiac neural crest cells were explanted and treated with FGF8b
plus the neutralizing antibodies alone or in combination. Cardiac
neural crest cells exposed to either of the function-blocking antibodies
migrated signiﬁcantly less than cells exposed to FGF8 without
antibody (Fig. 2C) and were comparable to cultures treated with
SU5402. There was no additive effect of FGFR1 and R3 when both
antibodies were used together (data not shown).
These results suggest that FGFR1 and R3 are the receptors important
for FGF8 enhanced cardiac neural crest cell migration. Because
knockdown of either receptor has the same effect while knockdown
of both receptors together does not have an additive effect these results
are consistent with FGF receptor heterodimerization. Disruption of
FGFR3 seems to be slightly more effective at disrupting FGF8-induced
migration, which may be a reﬂection of the increased colocalization
with the neural crest observed in the immunostain (Fig. 2B).
pErk, PI3K and p38 intracellular signaling is required for cardiac neural
crest response to FGF8
FGF signaling activates both Ras-dependent and Ras-independent
intracellular signaling pathways. To ascertain which intracellular
signaling pathways are activated by FGFR1 and R3 to modulate cardiac
neural crest cell migration, explants were treated with chemical
inhibitors of Mek/Erk, p38, phosphotide inositol 3 kinase (PI3K) and
the phospholipase C (PLC)γ signaling cascades alone or in combination
with 30 ng/ml FGF8b. Cultured cardiac neural crest explants treated
with Mek inhibitor (U0126) and PI3K inhibitor showed dramatic
inhibition of FGF8 induced migration. Inhibition of p38 signaling
showed moderate but signiﬁcant inhibition of migration while
inhibition of PLCγ (U73122) had no effect on migration (Fig. 2D).Fig. 2.Migratory response of cardiac neural crest cells to FGF8 depends on FGFR1 and R3 and t
with scrambled (Control), FGFR1, R2 or R3 morpholinos. The cardiac neural crest region was e
FGFR3morpholino causeda signiﬁcant reduction in single cellmigrationwhile FGFR1morpholin
migration. (B) Antibodies (red) to FGFR1 and R3 show that these receptors are expressed in th
HH12. (C) The FGFR1 and R3 antibodies are function-blocking due to the signiﬁcant reduction
SU5402 or with the antibodies. (D) Migratory response of cardiac neural crest depends on R
overnight with indicated intracellular inhibitors. Inhibition of p38, PI3K andMek signiﬁcantly b
induced cardiac neural crest migration. * denotes signiﬁcant difference from Control; ** denotThese results indicate that migrating cardiac neural crest cells utilize
the Ras (p38 and Mek/Erk) and calcium dependent PI3K intracellular
signaling cascades as they migrate towards the caudal pharynx.
FGF8 is chemokinetic and chemotactic for CNC in vivo
Our in vitro results indicated that inhibiting the function of
either FGFR1 or R3 blocked the migratory effect of FGF8 on the
cardiac neural crest. To determine whether the in vivo chemokinetic
effect of FGF8 on cardiac neural crest migration could be altered by
knocking down FGFRs, a dominant negative (dn)FGFR1-GFP expres-
sing plasmid was electroporated into the premigratory cardiac
neural crest. The embryos were harvested at HH15–18 for assay of
migration, proliferation, and apoptosis. GFP-positive cardiac neural
crest cells migrated robustly from the neural tube into the caudal
pharynx. In contrast, cardiac neural crest cells expressing dnFGFR1-
GFP migrated poorly from the neural tube and few to none entered
the pharynx (Figs. 3A–D). To measure the distance traveled by
individual electroporated cells, the embryos were sectioned and co-
immunostained for GFP and HNK1. The dnFGFR1-GFP-positive
cardiac neural crest cells lagged behind unelectroporated HNK1-
positive migrating cardiac neural crest cells while cells electro-
porated with GFP were evenly distributed throughout the migrating
HNK1-positive cells (Figs. 3E–K). This is somewhat surprising
because it suggests that single cardiac neural crest cells do not
migrate obligatorily with the group as has been shown for Sdf1
another chemotactic factor for neural crest cells (Kasemeier-Kulesa
et al., 2010; Theveneau et al., 2010) although there seems to be a
collective effect when the embryos are treated with SU5402 and the
FGFR3 blocking antibody (see below). The mitotic index calculated
by BrdU incorporation was no different for dnFGFR1, control, and
unmarked cardiac neural crest cells during migration (data not
shown). However, TUNEL staining for apoptosis indicated that the
dnFGFR1-GFP-positive cells showed an increase in cell death near
the neural tube (Figs. 3L–T) conﬁrming that FGF not only enhances
migration but also is a survival factor for cardiac neural crest as has
been shown previously in FGF8 hypomorphic mice (Abu-Issa et al.,
2002; Frank et al., 2002).
To determine if blocking FGF signaling globally would alter the
migration of cardiac neural crest cells, HH9 embryos were exposed
to the FGFR1 receptor blocking drug SU5402 or to our previously
tested FGFR3 neutralizing antibody, or both SU5402 and FGFR3
antibody. The embryos were harvested at HH14 when the cells
should be migrating into pharyngeal arch 3. In SU5402-treated
embryos (7 of 9) and FGFR3 antibody-treated embryos (3 of 6),
fewer cardiac neural crest cells migrated and those that did
exhibited delayed and poor migration as compared with stage-
matched controls (Figs. 3A,B,D and E). Delayed migration by the
cardiac neural crest cells was conﬁrmed in whole mount HNK1
stained embryos and in transverse sections (Fig. 4). Treatment
with both SU5402 and FGFR3 antibody resulted in severely
disrupted migration of the cardiac neural crest cells in 6 out of
6 embryos analyzed (Fig. 4C). This result suggests that migration
of the cardiac neural crest in vivo is enhanced by an FGF signal.
We have previously shown that treating embryos with SU5402 at
these stages results in overriding aorta in more than 50% of
embryos (Hutson et al., 2006). Because this is not an outﬂow
septation defect but a malalignment defect, it suggests that thereheMAPK/ERK signaling cascade. (A) Cardiac neural crest cells were electroporated at HH9
xplanted and individual cell migration followed for 16 h in the presence of 30 μg/ml FGF8.
o causeda tendency toward lessmigration. By contrast FGFR2morpholino hadnoeffect on
e migrating cardiac neural crest cells identiﬁed by HNK1 co-immunoreactivity (green) at
in migration in response to FGF8b. There was no difference between explants grownwith
as and PI3K intracellular signaling pathways. Cardiac neural crest explants were grown
locked FGF8b enhanced cardiac neural crestmigration. PLCγ inhibition did not block FGF8-
es signiﬁcant difference from FGF8 only.
23A. Sato et al. / Developmental Biology 354 (2011) 18–30are sufﬁcient numbers of cardiac neural crest cells to orchestrate
outﬂow septation but not enough to reduce FGF signaling in the
pharynx resulting in FGF oversignaling to the secondary heart ﬁeld
and subsequent arterial pole malalignment defects.These results conﬁrm that enhanced migration in vivo by cardiac
neural crest in response to FGF8 is receptor-mediated and further that
failure of the cells to leave the proximity of the neural tube is
associated with enhanced mortality.
Fig. 3. dnFGFR1-GFP cardiac neural crest cells show delayed migration and elevated cell death. (A) HH17 chick embryo control expressing GFP (green) shows cardiac neural crest
cells migrating into the pharyngeal arches. (B) Magniﬁcation of the gray box shown in A showing GFP-positive cells migrating midway into pharyngeal arches. (C) HH18–19 embryo
expressing dnFGFR1-GFP in the cardiac neural crest showed delayed cardiac neural crest migration with no cells in the pharynx. (D) Magniﬁcation of the gray box shown in C.
(E) Transverse section through arch 3 of HH16 chick embryo electroporated with GFP-expressing plasmid. HNK1 (red) shows migrating cardiac neural crest cells. GFP (green) is
expressed by cells throughout themigrating stream. (F) Magniﬁcation of right arch 3 showing a wide distribution of GFP electroporated cells throughout themigrating cardiac neural
crest stream. (G) Migrating cardiac neural crest stream in right arch 3 with GFP expressing cells mostly located distally. (H) Transverse sections through arch 3 of an HH16 chick
embryo electroporated with dnFGFR1-GFP. The migrating cardiac neural crest streams can be seen just dorsal and lateral to the foregut. (I) Magniﬁed view of the cardiac neural crest
stream showing that the dnFGFR1-GFP expressing cells are always located dorsally at the tail end of the stream. (J) Magniﬁed view of the cardiac neural crest stream from another
section of the same embryo showing a single dnFGFR1-GFP expressing cell also located at the dorsal end of the stream. (K) Graphic representation of the number of control-GFP-
positive cells or dnFGFR1-GFP-expressing cells and distance from the neural tube migrated by each population. Distance from the neural tube is indicated as 100% when the cells are
in the ventral pharynx on the x-axis. The y-axis indicates the number of cells per section. The majority of dnFGFR1 expressing cells could successfully migrate only about 20% of the
distance from the neural tube to the ventral pharynx with a few cells migrating 50% of the distance. By contrast the majority of GFP-positive age matched control cells migrated 40–
100% of the distance. TUNEL analysis (L–T) showed increased cell death in the dnFGFR1-GFP expressing cells. Cell death was highest near the neural tube leaving few cells to continue
migrating. (L) Transverse section of pharyngeal arch 2–3 level showing the position of panels M, N and O. Apoptosis (red) within cardiac neural crest expressing GFP was rare in the
cells nearest the neural tube (M), moderate midway to the arches (N), and more frequent once the cells reach the arch (O). (P) Transverse section of the arch 3 level in an embryo
electroporated with dnFGFR1-GFP showing the position of panels Q, R, and S. Apoptosis of cardiac neural crest cells was very high near the neural tube (Q), still moderately high
midway to the arches (R) and very lowwithin the arch (S) because almost no dnFGFR1-electroporated cardiac neural crest cells reach the arches. Yellow arrows indicate cells double
positive for GFP and TUNEL. (T) Bar graph indicating the number of TUNEL-positive cardiac neural crest cells and their position in the cardiac neural crest migratory pathway.
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As a ﬁrst attempt to determine whether FGF8 is chemotactic for
cardiac neural crest cells in vivo, GFP-FGF8b plasmid was electro-
porated into the neural tube at HH10 to establish an ectopic source of
FGF8 as the cells migrate. Embryoswere harvested at HH13, which is a
timepoint after most cardiac neural crest cell migration from the
neural tube. The migrated cells at this stage should be in thecircumpharyngeal ridge and beginning to enter pharyngeal arch 3
dorsally (Kuratani and Kirby, 1992;Waldo et al., 1996).We found that
cardiac neural crest cells ectopically expressing FGF8 delaminated
from the neural tube but then formed a clump of cells that did not
migrate toward the pharyngeal arches (Suppl. Fig. 3). While this
shows that cardiac neural crest cells ectopically expressing FGF8 are
not able to migrate distally from the dorsal neural tube, it does not
show that FGF8 is a chemotactic signal for the cells.
Fig. 4. Blocking FGF8 signaling with SU5402 or FGFR3 antibody delays cardiac neural crest migration in vivo. (A–C) Embryos treated with vehicle (control), FGFR3 antibody or
SU5402 plus FGFR3 antibody at HH9–10 and viewed in whole mount after HNK1 (green) immunohistochemistry. (A) Control treated embryos show normal cardiac neural crest cell
migration into the circumpharyngeal ridge and pharyngeal arch 3 (arrows). (B) Embryos treated with FGFR3 antibody show reduced migration into the circumpharyngeal ridge and
pharyngeal arch 3. (C) Embryos treated with SU5402 plus FGFR3 show poor migration of cardiac neural crest cells into the circumpharyngeal ridge and pharyngeal arch 3. (D)
Transverse section of HH16 control embryo stained with HNK1 (green) showing cardiac neural crest migration into the 3rd pharyngeal arch approximately 60 μm caudal to the otic
vesicle. Arrows indicate most distal migrating cardiac neural crest cells. (E) Comparable section in an HH16 embryo treated with SU5402 showing delayed migration of the cardiac
neural crest cells (green).
25A. Sato et al. / Developmental Biology 354 (2011) 18–30A deﬁnitive test of whether FGF8b serves as a chemotactic signal
for cardiac neural crest in vivo would be to show that the cells migrate
toward an ectopic source of FGF8. This can be accomplished by
placement of beads coated with FGF8 or by electroporation of an FGF8
expressing plasmid into a site that does not normally express FGF8.
Individual beads soaked in 30 μg/ml recombinant FGF8b or PBS were
placed lateral to the postotic neural tube at HH9. At HH14–15 in
embryos implanted with control PBS beads, the postotic cardiac
neural crest hadmigrated to the dorsal caudal pharynx as indicated by
HNK1 staining (Figs. 5A and C). In embryos with FGF8 beads, theFig. 5. Cardiac neural crest cells migrate toward ectopic sources of FGF8. (A,B,C,D) Whole m
cranial to somite 1. (A) PBS bead (white circle) with normal cardiac neural crest migration
beads (white circle) showing no distal migration of the cardiac neural crest (asterisks) and so
cardiac neural crest cell migration into pharyngeal arch 3 and the circumpharyngeal ridge. (
some HNK1 positive cells collected on the proximal side of the bead. (E) Enlargement of thcardiac crest could not be seen in the pharyngeal region but HNK1-
positive cells had collected dorsal to the bead (Figs. 5B, D, and E).
Because bead implantation disturbs the architecture of the
pharynx and could disrupt neural crest migration pathways, an
FGF8-expressing plasmid was electroporated into an ectopic site in
the ventral pharyngeal endoderm. A further advantage of this method
is that it provides a constant source of FGF8 and the opportunity to
determine whether arterial pole defects result from FGF8 over-
signaling in the presence of cardiac neural crest. FGF8 is normally
expressed only in the lateral pharyngeal endoderm and ectodermount embryos immunostained with HNK1 at HH14. Beads were implanted at HH9 just
into pharyngeal arch 3 (asterisk) and the circumpharyngeal ridge (asterisk). (B) FGF8
me cells clustered on the proximal side of the beads (arrow). (C) PBS bead with normal
D) FGF8 bead showing no migration of the cardiac neural crest distal to the bead with
e bead shown in D.
26 A. Sato et al. / Developmental Biology 354 (2011) 18–30(Karabagli et al., 2002). Ectopic fgf8 expression was markedly higher
than endogenous expression as conﬁrmed by simultaneous assess-
ment of GFP and fgf8 message expression by in situ hybridization
(Figs. 6A–D).
We and others have shown that too much or too little FGF
signaling in the pharynx is detrimental to neural crest and secondary
heart ﬁeld development (Abu-Issa et al., 2002; Frank et al., 2002;
Hutson et al., 2006). pErk immunohistochemistry was used to assess
signaling intensity of the ectopic foci of FGF8 in the pharynx at the
protein level. Interestingly, pErk intensity in the cardiac neural crest
cells was the same in control and FGF8-overexpressing embryos and
there was little to no pErk immunostaining in the secondary heart
ﬁeld (Suppl. Fig. 2). Because strong FGF signaling has the potential to
induce expression of negative regulators of pErk, downstream FGF
target expression was assessed by in situ hybridization and qPCR. The
caudal ventral pharynx in the region of FGF8 overexpression was
collected for qPCR of known FGF8 downstream target genes. Genes
assessed included positively regulated FGF targets: erm, pea3, and
er81; and negative feedback regulators of FGF signaling: mkp3, spry1,
spry2, and sef. None of the positive targets of FGF signaling was
elevated in the caudal pharynx; however, all of the negative
regulators with the exception of sef were upregulated (Fig. 6E).Fig. 6. Molecular effects of FGF8 overexpression in the ventral pharynx. (A) Whole mount H
pharynx. (B) Transverse section of arch 3 showing that FGF8b-GFP expression is limited t
expression by the electroporated endodermal cells. Arrowhead indicates ectopic FGF8. (D)
pharyngeal endoderm and ectoderm (arrowheads) of an unelectroporated embryo. This p
development of the endogenous signal. (E) Quantitative PCR of the ventral pharyngeal m
increase in the pea3 family of positive regulators in embryos electroporated with FGF8b. * in
sections of arch 3 in HH16 embryos electroporated with GFP alone (Sham/GFP) or FGF8b-GF
cells (arrows) express mkp3 and spry1 at high levels normally and this is not altered by e
expression by the ventral pharyngeal mesoderm also known as secondary heart ﬁeld (arroTo resolve how the speciﬁc regions of the caudal pharynx were
responding to FGF8 overexpression, in situ hybridization was
performed for several FGF8 target genes. Expression of the negative
feedback genes, mkp3, spry1, spry2, were very high in the cardiac
neural crest normally and were not further upregulated by ectopic
FGF8 expression (Fig. 6F). However, the negative feedback genes were
upregulated in the secondary heart ﬁeld (ventral pharyngeal
splanchnic mesoderm) (Fig. 6E). Signiﬁcantly both spry1 and 2
were signiﬁcantly up-regulated in the secondary heart ﬁeld splanch-
nic mesoderm conﬁrming previous studies showing that this cell
population is particularly sensitive FGF8 levels (Hutson et al., 2006).
Interestingly, ectopic FGF8 overexpression in the ventral pharynx
of HH16–18 embryos caused a dramatic increase in thickness of the
mesenchyme between the endoderm and ventral pharyngeal meso-
derm at the site of FGF8 overexpression (Figs. 7A and B). To determine
whether the increased mesenchyme was due to increased prolifera-
tion, phosphoHistone H3 (pHH3) expression was assayed in the area.
No difference in proliferation was found (Figs. 7C and D). Cell death as
assayed by TUNEL showed a slight increase in the thickened
mesenchyme (Figs. 7E and F).
Another potential explanation of the increasedmesenchyme given
the chemotactic and chemokinetic effect of FGF8 on cardiac neuralH14 embryo after electroporation with FGF8b-GFP (green) showing expression in the
o the ventral pharyngeal endoderm. (C) In situ hybridization for fgf8 showing robust
In situ hybridization showing the normal expression pattern of fgf8 expression in the
attern is not seen in C because the ectopic site of fgf8 expression was too strong for
esoderm shows upregulation of all the FGF8 downstream negative regulators but no
dicates statistical signiﬁcance compared to GFP electroporated controls. (F) Transverse
P either unilaterally or bilaterally followed by in situ hybridization. Cardiac neural crest
ctopic FGF8 overexpression. However, there is a dramatic increase in spry1 and spry2
wheads). Primer sequences are listed in Supplemental Table 2.
Fig. 7. Cells accumulate around an ectopic focus of FGF8 in the ventral pharynx. (A, A’) Transverse sections at HH18 in Sham–GFP and FGF8b-GFP electroporated embryos showing
increased thickness (double-headed arrow) of the mesenchyme separating the pharyngeal endoderm and the ventral pharyngeal mesoderm (secondary heart ﬁeld) in the FGF8b-
GFP electroporated embryo when compared to Sham–GFP electroporated embryo. (B) Bar graph illustrates that the thickness of the region around the FGF8 overexpression site is
increased by about 30% (n=4 embryos). (C, C’) Transverse sections of the arch 3 region of GFP and FGF8b-expressing HH16 embryos stained with phosphohistone H3 (pHH3-red) to
indicate dividing cells. (D) Bar graph showing the mitotic index of cells in the secondary heart ﬁeld (SHF) or pharyngeal mesenchyme is not different. (E, E’) Transverse sections of
the arch 3 region of GFP (control) and FGF8b expressing HH16 embryos that have been labeled for TUNEL to indicate dying cells (red). (F) Bar graph showing numerical data
indicating that apoptosis is slightly increased in secondary heart ﬁeld ventral to pharyngeal pouch 3 at stage 16.
Fig. 8. Cardiac neural crest cells are attracted to a site of FGF8 overexpression. (A) Premigratory cardiac neural crest cells labeled with DiI in the neural tube migrate to an ectopic site
of FGF8 expression. (B) Enlarged box in A. (C, D) Transverse sections through the arch 3 region of HH16 quail-chick chimeras expressing GFP alone or GFP-FGF8 in the ventral
pharynx. Cardiac neural crest cells are recognized by their reactivity with the quail antibody QCPN (red) and can be seen in the vicinity of the FGF8 overexpression (green).
27A. Sato et al. / Developmental Biology 354 (2011) 18–30
28 A. Sato et al. / Developmental Biology 354 (2011) 18–30crest is that more cardiac neural crest cells are attracted to the ectopic
site of FGF8 expression. To establish if this was the case, FGF8b-
expressing plasmid was electroporated into the foregut endoderm
and the neural tube was injected with DiI to label the premigratory
neural crest cells in HH9 embryos. At HH16 DiI-labeled cells had
migrated to the ectopic site of FGF8 expression in greater numbers
than when compared to the unelectroporated side (Figs. 8A and B). To
conﬁrm that these cells were cardiac neural crest cells, cardiac neural
crest quail–chick chimeras were constructed in embryos with the
FGF8b-expressing plasmid electroporated into the foregut endoderm.
The thickened mesenchyme near the site of FGF8b overexpression
was populated by a mixture of chick cells and quail cardiac neural
crest cells (Figs. 8C and D). The cardiac neural crest cells gathered
around the ectopic site of FGF8 expression had moved farther than
normal into the ventral pharynx for this time in development. These
results conﬁrm the in vitro ﬁnding that FGF8b is both chemotactic and
chemokinetic for cardiac neural crest cells.
Ectopic overexpression of FGF8 causes subtle changes in outﬂow tract
development
Elevated FGF8 signaling in the caudal pharynx after cardiac neural
crest ablation has been shown previously to cause abnormal arterial
pole development. Abnormal development is ﬁrst apparent at HH18
in the form of abnormal cardiac looping and subsequently at day 9
(HH34) as malalignment defects such as overriding aorta and
pulmonary stenosis/atresia (Hutson et al., 2006). We hypothesized
that ectopic overexpression of FGF8 would result in these cardiac
abnormalities even in the presence of cardiac neural crest. However,
at HH18 cardiac looping was normal in embryos electroporated with
FGF8b-expressing plasmid (not shown). We allowed the electro-
porated embryos to develop to day 9 of incubation when the
development of the 4-chambered heart is essentially complete.Fig. 9. Ectopic overexpression of FGF8 in the ventral pharynx results in mild pulmonary sten
embryo shown in A at day 9. Development of the arterial pole is normal. (C) HH18 embryo el
C at incubation day 9. The pulmonary trunk looks relatively normal (compare with outlined
position and size of the aorta and pulmonary trunk. (G,H) Transverse sections of the heart sho
but the pulmonary trunk at the level of the semilunar valves is slightly stenotic (compare le
defects from embryos with bilateral or unilateral sites of FGF8 overexpression.While none of the embryos had outﬂow alignment defects, we
found that 30–40% of the overexpressing embryos had slight
pulmonary stenosis (Fig. 9, Suppl. Table 3). The pulmonary stenosis
was at the level of the pulmonary semilunar valve (Figs. 9G and H).
Since the right side of secondary heart ﬁeld gives rise to the
subpulmonary myocardium, we compared whether electroporation
of FGF8b bilaterally or unilaterally on the right yielded the same
phenotype. A similar rate of pulmonary stenosis was found in either
condition (Fig. 9I), possibly because the negative regulators of FGF
signaling are maximally activated bilaterally even with unilateral
overexpression (Fig. 6E).
Discussion
Our results show that FGF8 is both chemotactic and chemokinetic
for cardiac neural crest cells in culture and as they originate from the
postotic rhombomeres 6,7, and 8 and migrate into pharyngeal arches
3, 4, and 6. Further we show that the migratory response is mediated
by FGFR1 and R3 via Ras and Ca2+-dependent intracellular signaling.
More cranialmesencephalic neural crest cells have also been shown to
be attracted to FGF8 in vitro but not in vivo where FGF2 was
chemotactic (Kubota and Ito, 2000). Interestingly neural crest cells
originating from rhombomere 4 (preotic) are attracted into pharyn-
geal arch 2 by VEGF (McLennan et al., 2010). Cardiac neural crest cells
destined for the caudal arches are not attracted by VEGF.
Several FGF ligands are expressed in the appropriate time frame
near the caudal rhombencephalon that could act as chemokines. A
detailed analysis of the hindbrain distribution of various components
of the FGF pathway has been documented by Weisinger et al. (2010).
The two closest sources of FGF8 to the caudal rhombencephalon are
the isthmus (Crossley et al., 1996) and the pharyngeal endoderm/
ectoderm (Farrell et al., 2001; Wendling et al., 2000). Both of these
sites are at least 100 μm away from the cardiac neural crest prior to itsosis. (A) HH18 embryo electroporated with GFP-expressing plasmid. (B) Heart from the
ectroporated with FGF8b-GFP-expressing plasmid. (D) Heart from the embryo shown in
area in B). (E,F) Transverse sections of the arterial pole of the heart in B showing normal
wn in D indicate that the position of the aorta (Ao) and pulmonary trunk (PT) is normal
ngth of double-headed arrows). (I) Quantitative assessment of hearts with arterial pole
29A. Sato et al. / Developmental Biology 354 (2011) 18–30migration. FGF3 and 19 are also expressed in rhombomere 6 at about
the time the cardiac neural crest cells migrate (Weisinger et al., 2010)
and FGF19 is expressed in the placodal ectoderm (Kurose et al., 2004)
but not in the pharyngeal arches. FGF signaling is likely because
pErk1/2 is strongly expressed at HH8 and a target and negative
regulator of FGF signaling,MKP3 is strongly expressed in rhombomere
6 at HH9. The FGF target genes, Pea3 and Erm are expressed
throughout the hindbrain at the time of cardiac neural crest migration
and their expression is downregulated by SU5402 treatment
suggesting that their expression is the result of FGF signaling. We
have shown that FGF3 does not promote either chemokinesis or
chemotaxis by cardiac neural crest. FGF19 could be chemokinetic for
cardiac neural crest; however, FGF19 is not present in the caudal
pharynx, signals through FGFR4 and requires the cofactor betaKlotho
for signaling through this receptor (Ito et al., 2000; Wu et al., 2009).
Expression of betaKlotho has not been reported in the caudal pharynx.
Thus, we favor FGF8 in the pharyngeal endoderm/ectoderm as being
the early chemotactic signal as it seems somewhat unlikely that a
chemotactic signal would originate from the source rather than the
target of migrating cells (Weisinger et al., 2010) and the caudal
pharynx is the target of cardiac crest cells. This is supported by our in
vitro studies showing that FGF3 was not chemokinetic for the cardiac
neural crest explants while under the same conditions FGF8 was. We
have not addressed whether these FGFs might be chemorepellent.
While this could certainly be the case, the results from our transwell
studies do not favor FGF8 acting as such.
This leaves open the question of how a signal emanating from the
pharynx might inﬂuence cells in the dorsal neural tube. Graded levels
of FGF protein have been shown to span relatively long distances by
binding heparan sulfate proteoglycans which localize FGF distribution
and enhance the avidity withwhich FGF binds its receptor (Chen et al.,
2009). Using a reporter construct, Chen et al. (2009) found a gradient
of FGF signaling in the caudal hindbrain. Heparin sulfate proteogly-
cans are composed of a protein core surrounded by covalently linked
heparan sulfate chains composed of disaccharide repeats (Bernﬁeld
et al., 1999; Prydz and Dalen, 2000). Several heparin sulfate-
modifying enzymes that generate distinct sulfation patterns have
been discovered. One of these, Sulf1, is an extracellular endosulfatase
that eliminates the sulfate group in position 6-O of glucosamine in
highly sulfated regions of HS (Ai et al., 2003; Ai et al., 2007;Morimoto-
Tomita et al., 2002). At HH12 Sulf1 is expressed in the developing
caudal pharyngeal region (Garcia-Lopez et al., 2009) suggesting that
an FGF8 gradient could exist in the caudal pharynx. The fact that
sprouty was upregulated bilaterally in the secondary heart ﬁeld after
unilateral overexpression supports the idea that the FGF8 signal is
widely distributed.
Neural crest cells have been reported previously to chemotax
toward several diffusible signals, including but not limited to FGF2,
Sdf1, VEGF and semaphorins (Kasemeier-Kulesa et al., 2010; Kubota
and Ito, 2000; McLennan et al., 2010; Olesnicky Killian et al., 2009;
Theveneau et al., 2010; Toyofuku et al., 2008). FGF2 is chemotactic for
mesencephalic neural crest cells (Kubota and Ito, 2000). These
investigators speculated that the chemotaxis was mediated by
FGFR1 and R3, which were the two receptors that were highly
expressed by mesencephalic neural crest cells. Interestingly, our data
also suggest that FGFR1 and R3 are the most highly expressed of the
FGFRs in the cardiac neural crest. A double knockdown of FGFR1 and
R2 using Wnt1cre or AP2cre did not cause any neural crest-related
defects (Park et al., 2008). Thus it is possible that FGFR3 is able to
mediate the signaling needed in the cardiac neural crest cells. An
alternate explanation is that the receptor knockdown by Wnt1cre or
AP2cre could be too late to block the FGF signal.
Park et al. (2008) also induced conditional overexpression of
sprouty in the neural crest. This would be expected to inhibit Mek/Erk
signaling which according to our data should disrupt cardiac neural
crest migration. However, sprouty overexpression did not affectcardiac neural crest behavior (Park et al., 2008). In mice, the caudal
arches are pErk positive at E9.0 but negative by E9.5–10 when cardiac
neural crest has populated these arches (Corson et al., 2003). Because
our data show that cardiac neural crest cells express high levels of
sprouty in the pharyngeal arches, it is possible again that sprouty
overexpression would not disrupt neural crest function. By the time
the cardiac neural crest cells reach the pharynx, they are most likely
refractory to FGF8 signaling because of the high level of expression of
negative regulators of FGF8 intracellular signaling.
Further, of great interest to us was the ﬁnding that FGF8
overexpression in the presence of cardiac neural crest does not lead
to the same type of abnormal development of the secondary heart
ﬁeld and arterial pole that occur when cardiac neural crest does not
migrate to the caudal pharynx. This suggests that cardiac neural crest
cells not only migrate to a pharyngeal site of FGF8 production but also
can modulate the availability of signaling during the window when
intracellular inhibitors of FGF8, like sprouty can be upregulated in the
secondary heart ﬁeld. We, and others, have recently shown that
signaling through the Mek/Erk pathway is important for inhibiting
BMP-induced myocardial differentiation (Hutson et al., 2010; Tirosh-
Finkel et al., 2010). Because of the intense sprouty expression in the
secondary heart ﬁeld, signaling through the Mek/Erk pathwaymay be
totally suppressed which would allow premature differentiation of
the progenitors. The phenotype seen after FGF8 overexpression is a
mild pulmonary stenosis, which would be predicted to result from
premature myocardial differentiation at the expense of proliferative
expansion of the cardiogenic stem cell population in the secondary
heart ﬁeld. It remains to be determined how cardiac neural crest cells
might modulate FGF8 levels.
Finally, Trumpp et al. (1999) found that tissue speciﬁc inactivation
of FGF8 in the ectoderm of pharyngeal arch 1 caused cell death and
impaired development of arch 1 (Trumpp et al., 1999). Also
hypomorphic expression of FGF8 resulted in increased mesenchymal
cell death (Abu-Issa et al., 2002; Frank et al., 2002). Our experiments
also indicate that cardiac neural crest cells unable to transduce the
FGF8 signal because of the expression of dominant negative FGFR1
results in cell death. However, in our experiments overexpression of
FGF8 did not result in an increase in proliferation although cell death
was slightly elevated in the ventral pharynx. Thus the increased
mesenchymal thickness at a site of ectopic FGF8 expression appears
not to be due to either an increase in proliferation or a decrease in cell
death.
Supplementarymaterials related to this article can be found online
at doi:10.1016/j.ydbio.2011.03.010.Acknowledgments
This work was funded by a postdoctoral fellowship from the
American Heart Association to AS, The Cincinnati Children's Heart
Foundation (MLK), the George and Jean Brumley, Jr. Neonatal-
Perinatal Research Institute of Duke University, AHA0830464N
(MRH) and NIH grants HL083240 and HL070140 (MLK).References
Abu-Issa, R., Smyth, G., Smoak, I., Yamamura, K.-I., Meyers, E., 2002. Fgf8 is required for
pharyngeal arch and cardiovascular development in the mouse. Development 129,
4613–4625.
Ai, X., Do, A.T., Lozynska, O., Kusche-Gullberg, M., Lindahl, U., Emerson Jr., C.P., 2003.
QSulf1 remodels the 6-O sulfation states of cell surface heparan sulfate
proteoglycans to promote Wnt signaling. J. Cell Biol. 162, 341–351.
Ai, X., Kitazawa, T., Do, A.T., Kusche-Gullberg, M., Labosky, P.A., Emerson Jr., C.P., 2007.
SULF1 and SULF2 regulate heparan sulfate-mediated GDNF signaling for esopha-
geal innervation. Development 134, 3327–3338.
Bernﬁeld, M., Gotte, M., Park, P.W., Reizes, O., Fitzgerald, M.L., Lincecum, J., Zako, M.,
1999. Functions of cell surface heparan sulfate proteoglycans. Annu. Rev. Biochem.
68, 729–777.
30 A. Sato et al. / Developmental Biology 354 (2011) 18–30Chen, Y., Mohammadi, M., Flanagan, J.G., 2009. Graded levels of FGF protein span the
midbrain and can instruct graded induction and repression of neural mapping
labels. Neuron 62, 773–780.
Corson, L.B., Yamanaka, Y., Lai, K.M., Rossant, J., 2003. Spatial and temporal patterns of
ERK signaling during mouse embryogenesis. Development 130, 4527–4537.
Creuzet, S., Couly, G., Vincent, C., Le Douarin, N. M., 2002. Negative effect of Hox gene
expression on the development of the neural crest-derived facial skeleton.
Development 129, 4301–4313.
Crossley, P.H., Martinez, S., Martin, G.R., 1996. Midbrain development induced by FGF8
in the chick embryo. Nature 380, 66–68.
Dessimoz, J., Opoka, R., Kordich, J.J., Grapin-Botton, A., Wells, J.M., 2006. FGF signaling is
necessary for establishing gut tube domains along the anterior–posterior axis in
vivo. Mech. Dev. 123, 42–55.
Farrell, M.J., Burch, J.L., Wallis, K., Rowley, L., Kumiski, D., Stadt, H., Godt, R.E., Creazzo, T.L.,
Kirby, M.L., 2001. FGF-8 in the ventral pharynx alters development of myocardial
calcium transients after neural crest ablation. J. Clin. Invest. 107, 1509–1517.
Frank, D., Fotheringham, L., Brewer, J., Muglia, L., Tristani-Firouzi, Capecchi, M., Moon,
A., 2002. An Fgf8 mouse mutant phenocopies human 22q11 deletion syndrome.
Development 129, 4591–4603.
Garcia-Lopez, R., Soula, C., Martinez, S., 2009. Expression analysis of Sulf1 in the chick
forebrain at early and late stages of development. Dev. Dyn. 238, 2418–2429.
Harduf, H., Halperin, E., Reshef, R., Ron, D., 2005. Sef is synexpressed with FGFs during
chick embryogenesis and its expression is differentially regulated by FGFs in the
developing limb. Dev. Dyn. 233, 301–312.
Huang, G.Y., Cooper, E.S., Waldo, K., Kirby, M.L., Gilula, N.B., Lo, C.W., 1998. Gap
junction-mediated cell–cell communication modulates mouse neural crest migra-
tion. J. Cell Biol. 143, 1725–1734.
Hutson, M.R., Zhang, P., Stadt, H.A., Sato, A., Li, Y.-X., Burch, J., Creazzo, T.L., Kirby, M.L.,
2006. Cardiac arterial pole alignment is sensitive to FGF8 signaling in the pharynx.
Dev. Biol. 295, 486–497.
Hutson, M.R., Zeng, X.L., Kim, A.J., Antoon, E., Harward, S., Kirby, M.L., 2010. Arterial pole
progenitors interpret opposing FGF/BMP signals to proliferate or differentiate.
Development 137, 3001–3011.
Ito, S., Kinoshita, S., Shiraishi, N., Nakagawa, S., Sekine, S., Fujimori, T., Nabeshima, Y.I.,
2000. Molecular cloning and expression analyses of mouse betaklotho, which
encodes a novel Klotho family protein. Mech. Dev. 98, 115–119.
Karabagli, H., Karabagli, P., Ladher, R.K., Schoenwolf, G.C., 2002. Survey of ﬁbroblast
growth factor expression during chick organogenesis. Anat. Rec. 268, 1–6.
Kasemeier-Kulesa, J.C., McLennan, R., Romine, M.H., Kulesa, P.M., Lefcort, F., 2010.
CXCR4 controls ventral migration of sympathetic precursor cells. J. Neurosci. 30,
13078–13088.
Kirby, M.L., Gale, T.F., Stewart, D.E., 1983. Neural crest cells contribute to aorticopul-
monary septation. Science 220, 1059–1061.
Kirby, M.L., Hunt, P., Wallis, K.T., Thorogood, P., 1997. Normal development of the
cardiac outﬂow tract is not dependent on normal patterning of the aortic arch
arteries. Dev. Dyn. 208, 34–47.
Kubota, Y., Ito, K., 2000. Chemotactic migration of mesencephalic neural crest cells in
the mouse. Dev. Dyn. 217, 170–179.
Kuratani, S.C., Kirby, M.L., 1992. Migration and distribution of circumpharyngeal crest
cells in the chick embryo. Formation of the circumpharyngeal ridge and E/C8+
crest cells in the vertebrate head region. Anat. Rec. 234, 263–280.
Kurose, H., Bito, T., Adachi, T., Shimizu, M., Noji, S., Ohuchi, H., 2004. Expression of
Fibroblast growth factor 19 (Fgf19) during chicken embryogenesis and eye
development, compared with Fgf15 expression in the mouse. Gene Expr. Patterns
4, 687–693.
Le Lievre, C.S., Le Douarin, N.M., 1975. Mesenchymal derivatives of the neural crest.
Analysis of chimaeric quail and chick embryos. J. Embryol. Exp. Morphol. 34,
125–154.
Mayor, R., Guerrero, N., Mart¡nez, C., 1997. Role of FGF and noggin in neural crest
induction. Dev. Biol. 189, 1–12.
McLennan, R., Teddy, J.M., Kasemeier-Kulesa, J.C., Romine, M.H., Kulesa, P.M., 2010.
Vascular endothelial growth factor (VEGF) regulates cranial neural crest migration
in vivo. Dev. Biol. 339, 114–125.Monsoro-Burq, A.H., Wang, E., Harland, R., 2005. Msx1 and Pax3 cooperate to mediate
FGF8 andWNT signals during Xenopus neural crest induction. Dev. Cell 8, 167–178.
Morimoto-Tomita, M., Uchimura, K., Werb, Z., Hemmerich, S., Rosen, S.D., 2002. Cloning
and characterization of two extracellular heparin-degrading endosulfatases inmice
and humans. J. Biol. Chem. 277, 49175–49185.
Olesnicky Killian, E.C., Birkholz, D.A., Artinger, K.B., 2009. A role for chemokine signaling
in neural crest cell migration and craniofacial development. Dev. Biol. 333,
161–172.
Park, E.J., Ogden, L.A., Talbot, A., Evans, S., Cai, C.L., Black, B.L., Frank, D.U., Moon, A.M.,
2006. Required, tissue-speciﬁc roles for Fgf8 in outﬂow tract formation and
remodeling. Development 133, 2419–2433.
Park, E.J., Watanabe, Y., Smyth, G., Miyagawa-Tomita, S., Meyers, E., Klingensmith, J.,
Camenisch, T., Buckingham, M., Moon, A.M., 2008. An FGF autocrine loop initiated
in second heart ﬁeld mesoderm regulates morphogenesis at the arterial pole of the
heart. Development 135, 3599–3610.
Prydz, K., Dalen, K.T., 2000. Synthesis and sorting of proteoglycans. J. Cell Sci. 113 (Pt 2),
193–205.
Sarkar, S., Petiot, A., Copp, A., Ferretti, P., Thorogood, P., 2001. FGF2 promotes skeletogenic
differentiation of cranial neural crest cells. Development 128, 2143–2152.
Sato, T., Araki, I., Nakamura, H., 2001. Inductive signal and tissue responsiveness
deﬁning the tectum and the cerebellum. Development 128, 2461–2469.
Suemori, H., Kadodawa, Y., Goto, K., Araki, I., Kondoh, H., Nakatsuji, N., 1990. A mouse
embryonic stem cell line showing pluripotency of differentiation in early embryos
and ubiquitous beta-galactosidase expression. Cell Differ. Dev. 29, 181–186.
Sun, X., Meyers, E.N., Lewandoski, M., Martin, G.R., 1999. Targeted disruption of Fgf8
causes failure of cell migration in the gastrulating mouse embryo. Genes Dev. 13,
1834–1846.
Theveneau, E., Marchant, L., Kuriyama, S., Gull, M., Moepps, B., Parsons, M., Mayor, R.,
2010. Collective chemotaxis requires contact-dependent cell polarity. Dev. Cell 19,
39–53.
Tirosh-Finkel, L., Zeisel, A., Brodt-Ivenshitz, M., Shamai, A., Yao, Z., Seger, R., Domany, E.,
Tzahor, E., 2010. BMP-mediated inhibition of FGF signaling promotes cardiomyocyte
differentiation of anterior heart ﬁeld progenitors. Development 137, 2989–3000.
Toyofuku, T., Yoshida, J., Sugimoto, T., Yamamoto, M., Makino, N., Takamatsu, H.,
Takegahara, N., Suto, F., Hori, M., Fujisawa, H., Kumanogoh, A., Kikutani, H., 2008.
Repulsive and attractive semaphorins cooperate to direct the navigation of cardiac
neural crest cells. Dev. Biol. 321, 251–262.
Trumpp, A., Depew, M.J., Rubenstein, J.L., Bishop, J.M., Martin, G.R., 1999. Cre-mediated
gene inactivation demonstrates that FGF8 is required for cell survival and
patterning of the ﬁrst branchial arch. Genes Dev. 13, 3136–3148.
Wakamatsu, Y., Watanabe, Y., Nakamura, H., Kondoh, H., 1997. Regulation of the neural
crest cell fate by N-myc: promotion of ventral migration and neuronal
differentiation. Development 124, 1953–1962.
Waldo, K.L., Kumiski, D., Kirby, M.L., 1996. Cardiac neural crest is essential for the
persistence rather than the formation of an arch artery. Dev. Dyn. 205, 281–292.
Weisinger, K., Kayam, G., Missulawin-Drillman, T., Sela-Donenfeld, D., 2010. Analysis of
expression and function of FGF–MAPK signaling components in the hindbrain reveals
a central role for FGF3 in the regulation of Krox20, mediated by Pea3. Dev. Biol. 344,
881–895.
Wendling, O., Dennefeld, C., Chambon, P., Mark, M., 2000. Retinoid signaling is essential
for patterning the endoderm of the third and fourth pharyngeal arches.
Development 127, 1553–1562.
Wilkinson, D.G., 1992. In situ hybridization. In: Rickwood, D., Hames, B.D. (Eds.), In Situ
Hybridization: A Practical Approach. IRS Press, Oxford, pp. 75–83.
Wu, X., Ge, H., Lemon, B., Weiszmann, J., Gupte, J., Hawkins, N., Li, X., Tang, J., Lindberg,
R., Li, Y., 2009. Selective activation of FGFR4 by an FGF19 variant does not improve
glucose metabolism in ob/ob mice. Proc. Natl. Acad. Sci. U. S. A. 106, 14379–14384.
Xu, X., Francis, R., Wei, C.J., Linask, K.L., Lo, C.W., 2006. Connexin 43-mediated
modulation of polarized cell movement and the directional migration of cardiac
neural crest cells. Development 133, 3629–3639.
Yang, X., Dormann, D., Munsterberg, A., Weijer, C.J., 2002. Cell movement patterns
during gastrulation in the chick are controlled by positive and negative chemotaxis
mediated by FGF4 and FGF8. Dev. Cell 3, 425–437.
